EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury.
Nührenberg TG, Langwieser N, Schwarz JB, Hou Y, Frank P, Sorge F, Matschurat S, Seidl S, Kastrati A, Schömig A, Clauss MA, Zohlnhöfer D.
Nührenberg TG, et al. Among authors: zohlnhofer d.
Cardiovasc Res. 2008 Feb 1;77(3):580-9. doi: 10.1093/cvr/cvm076. Epub 2007 Nov 20.
Cardiovasc Res. 2008.
PMID: 18029408